Hims & Hers Health (HIMS) is presented as a strong buy opportunity due to its technical setup, fundamental tailwinds, international expansion, and significant growth potential in the peptide market, all at a 'dirt cheap' valuation.
Source Post
The creator discusses Hims & Hers Health (HIMS), highlighting its recent stock performance, fundamental str...
Mo InvestsJun 10, 2026
The creator discusses Hims & Hers Health (HIMS), highlighting its recent stock performance, fundamental strengths, and international expansion opportunities. They believe the company is undervalued and has significant growth potential, particularly in the peptide market and global reach, comparing it to the 'Netflix of healthcare'.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
HIMS
buy opened Jun 10, 2026
+17.12%